143 related articles for article (PubMed ID: 29073585)
1. Evaluation of phenytoin serum levels following a loading dose in the acute hospital setting.
Selioutski O; Grzesik K; Vasilyeva ON; Hilmarsson Á; Fessler AJ; Liu L; Gross RA
Seizure; 2017 Nov; 52():199-204. PubMed ID: 29073585
[TBL] [Abstract][Full Text] [Related]
2. Intravenous phenytoin: a retrospective analysis of Bayesian forecasting versus conventional dosing in patients.
Tobler A; Mühlebach S
Int J Clin Pharm; 2013 Oct; 35(5):790-7. PubMed ID: 23812678
[TBL] [Abstract][Full Text] [Related]
3. Coadministration of phenytoin and felbamate: evidence of additional phenytoin dose-reduction requirements based on pharmacokinetics and tolerability with increasing doses of felbamate.
Sachdeo R; Wagner ML; Sachdeo S; Shumaker RC; Lyness WH; Rosenberg A; Ward D; Perhach JL
Epilepsia; 1999 Aug; 40(8):1122-8. PubMed ID: 10448826
[TBL] [Abstract][Full Text] [Related]
4. In vivo binding characteristics of phenytoin to serum proteins in monotherapy pediatric patients with epilepsy.
Kodama H; Kodama Y; Shinozawa S; Kanemaru R; Itokazu N; Sugimoto T
Int J Clin Pharmacol Ther; 2000 Jan; 38(1):25-9. PubMed ID: 10667833
[TBL] [Abstract][Full Text] [Related]
5. Temperature effect on serum protein binding kinetics of phenytoin in monotherapy patients with epilepsy.
Kodama H; Kodama Y; Shinozawa S; Kanemaru R; Todaka K; Mitsuyama Y
Eur J Pharm Biopharm; 1999 May; 47(3):295-8. PubMed ID: 10382115
[TBL] [Abstract][Full Text] [Related]
6. In vivo binding characteristics of phenytoin to serum proteins in monotherapy for adults with epilepsy.
Kodama H; Kodama Y; Shinozawa S; Kanemaru R; Todaka K; Mitsuyama Y
Am J Ther; 2000 Nov; 7(6):359-63. PubMed ID: 11304643
[TBL] [Abstract][Full Text] [Related]
7. Phenytoin half-life and clearance during maintenance therapy in adults and elderly patients with epilepsy.
Ahn JE; Cloyd JC; Brundage RC; Marino SE; Conway JM; Ramsay RE; White JR; Musib LC; Rarick JO; Birnbaum AK; Leppik IE
Neurology; 2008 Jul; 71(1):38-43. PubMed ID: 18591503
[TBL] [Abstract][Full Text] [Related]
8. Effect of temperature on binding characteristics of phenytoin to serum proteins in monotherapy adult patients with epilepsy.
Kodama H; Kodama Y; Shinozawa S; Kanemaru R; Todaka K; Mitsuyama Y
Am J Ther; 2000 Jan; 7(1):11-5. PubMed ID: 11319568
[TBL] [Abstract][Full Text] [Related]
9. Safety, Tolerability, and Pharmacokinetics of Fosphenytoin Loading in Patients With Subarachnoid Hemorrhage.
Kim DW; Kim TE; Ji M; Chun YI
Clin Neuropharmacol; 2015; 38(6):248-51. PubMed ID: 26536021
[TBL] [Abstract][Full Text] [Related]
10. Use of IV fosphenytoin pharmacokinetics to determine the loading dose for a clinical trial of canine status epilepticus.
Coles LD; Leppik IE; Patterson EE; Rivers Z; Mishra U; Cloyd JC
Epilepsia; 2015 Jun; 56(6):888-94. PubMed ID: 25952988
[TBL] [Abstract][Full Text] [Related]
11. Vigabatrin-induced decrease in serum phenytoin concentration does not involve a change in phenytoin bioavailability.
Gatti G; Bartoli A; Marchiselli R; Michelucci R; Tassinari CA; Pisani F; Zaccara G; Timmings P; Richens A; Perucca E
Br J Clin Pharmacol; 1993 Dec; 36(6):603-6. PubMed ID: 12959280
[TBL] [Abstract][Full Text] [Related]
12. No gender effect on binding characteristics of phenytoin to serum proteins in monotherapy for adult patients with epilepsy.
Kodama H; Kodama Y; Shinozawa S; Kanemaru R; Todaka K; Mitsuyama Y
Am J Ther; 2000 Sep; 7(5):285-9. PubMed ID: 11317172
[TBL] [Abstract][Full Text] [Related]
13. Add-on phenytoin fails to prevent early seizures after surgery for supratentorial brain tumors: a randomized controlled study.
De Santis A; Villani R; Sinisi M; Stocchetti N; Perucca E
Epilepsia; 2002 Feb; 43(2):175-82. PubMed ID: 11903465
[TBL] [Abstract][Full Text] [Related]
14. Phenytoin use in elderly nursing home residents.
Birnbaum AK; Hardie NA; Conway JM; Bowers SE; Lackner TE; Graves NM; Leppik IE
Am J Geriatr Pharmacother; 2003 Dec; 1(2):90-5. PubMed ID: 15555471
[TBL] [Abstract][Full Text] [Related]
15. [A case of toxicity caused by drug interaction between capecitabine and phenytoin in patient with colorectal cancer].
Sakurai M; Kawahara K; Ueda R; Fukui E; Yamada R
Gan To Kagaku Ryoho; 2011 May; 38(5):841-3. PubMed ID: 21566450
[TBL] [Abstract][Full Text] [Related]
16. Efficacy, Tolerability and Serum Phenytoin Levels after Intravenous Fosphenytoin Loading Dose in Children with Status Epilepticus.
Srivastava K; Bhartiya S; Gavli V; Patil R; Rajadhyaksha S
Indian Pediatr; 2020 Mar; 57(3):218-221. PubMed ID: 32198860
[TBL] [Abstract][Full Text] [Related]
17. Topiramate and phenytoin pharmacokinetics during repetitive monotherapy and combination therapy to epileptic patients.
Sachdeo RC; Sachdeo SK; Levy RH; Streeter AJ; Bishop FE; Kunze KL; Mather GG; Roskos LK; Shen DD; Thummel KE; Trager WF; Curtin CR; Doose DR; Gisclon LG; Bialer M
Epilepsia; 2002 Jul; 43(7):691-6. PubMed ID: 12102670
[TBL] [Abstract][Full Text] [Related]
18. Efficacy, tolerability, and safety of rapid initiation of topiramate versus phenytoin in patients with new-onset epilepsy: a randomized double-blind clinical trial.
Ramsay E; Faught E; Krumholz A; Naritoku D; Privitera M; Schwarzman L; Mao L; Wiegand F; Hulihan J;
Epilepsia; 2010 Oct; 51(10):1970-7. PubMed ID: 20633037
[TBL] [Abstract][Full Text] [Related]
19. Peri-operative prophylaxis with phenytoin: dosage and therapeutic plasma levels.
Levati A; Savoia G; Zoppi F; Boselli L; Tommasino C
Acta Neurochir (Wien); 1996; 138(3):274-8; discussion 278-9. PubMed ID: 8861695
[TBL] [Abstract][Full Text] [Related]
20. Differences between the measured and calculated free serum phenytoin concentrations in epileptic patients.
Hong JM; Choi YC; Kim WJ
Yonsei Med J; 2009 Aug; 50(4):517-20. PubMed ID: 19718399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
